Toregem BioPharma, Co.,Ltd.
- Biotech or pharma, therapeutic R&D
Toregem Biopharma is a clinical stage biopharmaceutical company committed to a novel game changing drug.
We are developing a first-in-class antibody drug for a rare genetic disorder called congenital oligodontia. Congenital oligodontia cause severe oral dysfunction especially in children.
Since no approved pharmacological treatments exist, it can be positioned as a breakthrough in regenerative medicine and pediatric rare diseases.
In parallel, we are actively developing therapeutic formulations for the treatment of acquired tooth defects.
We are seeking a global clinical development and marketing partner.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}